Advances in Therapy Pharmacology (medical)

A Randomised, Double-Blind Trial to Compare the Efficacy, Safety, and Immunogenicity of the Biosimilar Ustekinumab FYB202 with Reference Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis

Kim Papp, Sigrid Balser, Katrin Nopora, Piotr Rewerski, Brigitte Freudensprung, Michael Trieb
Springer Nature · 2025-03-06 · DOI 10.1007/s12325-025-03138-2

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →